Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418610 · ClinicalTrials.gov registry record · Phase 4
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
A Phase 4 study, sponsored by Clinical Research Center of the Carolinas.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03418610 is a Phase 4 study that has completed, run by Clinical Research Center of the Carolinas. The registered enrollment target is 5 participants.
The verdict
NCT03418610, a Phase 4 study, has completed, sponsored by Clinical Research Center of the Carolinas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.
Interventions
- DRUG Azelaic Acid foam 15%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-12-06 |
| Est. Completion | 2019-01-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03418610
The ClinicalTrials.gov registry entry for NCT03418610 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Research Center of the Carolinas, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Azelaic Acid foam 15% is the first listed.
NCT03418610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03418610 about?
NCT03418610 is a clinical study titled "Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea". This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.
What is the current status of trial NCT03418610?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2017-12-06. Estimated completion is 2019-01-09.
What interventions are being tested in trial NCT03418610?
The interventions under investigation include: Azelaic Acid foam 15% (DRUG).
Who is sponsoring clinical trial NCT03418610?
This trial is sponsored by Clinical Research Center of the Carolinas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.